DHHIGH SIGNALFINANCIAL10-K

Definitive Healthcare shows dramatic improvement in profitability metrics with operating losses narrowing 68% while maintaining strong cash growth, but significant balance sheet contraction raises questions about underlying business changes.

The substantial improvement in operating income (loss reduction from $710.8M to $224.3M) and net income suggests either major cost restructuring or significant one-time charges in the prior period that have been resolved. However, the 37.6% decline in stockholders' equity coupled with a 32.5% reduction in total assets indicates potential asset write-downs, restructuring activities, or other balance sheet optimization efforts that investors should scrutinize carefully.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

The company exhibits a mixed but notable financial transformation, with dramatic improvements in profitability metrics (68% reduction in operating losses) and a 55% increase in cash position to $163.6M, while simultaneously reducing debt by 32%. However, the significant contraction across the balance sheet—including 37.6% decline in stockholders' equity and 32.5% reduction in total assets—alongside doubled share buybacks to $49.5M, suggests major structural changes or asset optimization that fundamentally reshaped the company's financial profile. This combination of improved cash flow generation with substantial balance sheet contraction warrants careful analysis of the underlying business transformation.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
+121.1%
$22.4M$49.5M

Share repurchases increased 121.1% — management returning capital, signals confidence in intrinsic value.

Operating Income
P&L
+68.4%
-$710.8M-$224.3M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+66.4%
-$413.1M-$138.9M

Net income grew 66.4% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+55.3%
$105.4M$163.6M

Cash position surged 55.3% — strong cash generation or capital raise providing significant financial cushion.

Stockholders Equity
Balance Sheet
-37.6%
$607.2M$379.0M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Capital Expenditure
Cash Flow
+35.5%
$12.3M$16.7M

Capital expenditure jumped 35.5% — major investment cycle underway; assess returns on deployment.

Total Assets
Balance Sheet
-32.5%
$1.1B$735.5M

Total assets contracted 32.5% — asset sales, write-downs, or balance sheet optimization underway.

Total Debt
Balance Sheet
-31.9%
$244.1M$166.3M

Debt reduced 31.9% — deleveraging strengthens balance sheet and reduces financial risk.

Current Assets
Balance Sheet
-30.4%
$370.2M$257.6M

Current assets declined 30.4% — monitor working capital adequacy and short-term liquidity.

Total Liabilities
Balance Sheet
-26.1%
$482.2M$356.5M

Liabilities reduced 26.1% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
TRA refers to the Tax Receivable Agreement between Definitive Healthcare Corp., Definitive OpCo, and the TRA Parties (as the term is defined below).
TRA Parties refers to the Continuing Pre-IPO LLC Members, the Reorganization Parties, and any future party to the TRA.
Overview Definitive Healthcare is a leading provider of healthcare data and analytics.
We provide accurate, comprehensive information on healthcare providers and their activities, enabling customers to make informed decisions across product development, go-to-market planning, and sales and marketing execution.
We also offer claims and consumer analytics built from modeled data on millions of unique consumers to help healthcare organizations target, message, and engage specific healthcare audiences.
+7 more — sign up free →
REMOVED
Tax Receivable Agreement refers to the Tax Receivable Agreement, dated September 14, 2021, between Definitive Healthcare Corp., Definitive OpCo, and the TRA Parties.
TRA Parties refers to the Continuing Pre-IPO LLC Members, the Reorganization Parties, and any future party to the Tax Receivable Agreement.
If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud.
As a result, our stockholders could lose confidence in our financial reporting, which could harm our business and the trading price of our common stock; and Our results of operations may be harmed if we are required to collect sales or other related taxes for subscriptions to our platform in jurisdictions where we have not historically done so.
Overview Definitive Healthcare is a leading provider of healthcare commercial intelligence.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →